20/12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

20/12/2024

Dec 20, 2024, 22:49 | Science
High-risk defining events in follicular lymphoma following front line immunochemotherapy
Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of…
Dec 20, 2024, 22:35 | Blog
Jennifer S. Buell: Transforming cancer care through innovation in immuno-oncology
Jennifer S. Buell, President and Chief Executive Officer at MiNK Therapeutics, posted the following on…
Dec 20, 2024, 21:30 | Science
Razelle Kurzrock: If it’s a solid tumor target, it may be a heme target
Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center,…
Dec 20, 2024, 21:15 | Blog
Cancer Discovery: Nominations for the Cancer Discovery Early Career Award
Cancer Discovery shared a post on X: "Reminder—nominations for the Cancer Discovery Early Career Award…
Dec 20, 2024, 18:43 | Insight
FDA Approves Remestemcel-L for Steroid-Refractory GvHD in Pediatric Patients
On December 18, 2024, FDA approved remestemcel-L-rknd (Ryoncil, Mesoblast, Inc.), an allogeneic bone marrow-derived mesenchymal…
Dec 20, 2024, 18:36 | Blog
Oracle Head and Neck Cancer UK Announced £300,000 Research Grant to Propel Innovation in Cancer Research and Patient Care
Oracle Head & Neck Cancer UK, in partnership with a family foundation, is excited to…
Dec 20, 2024, 18:34 | Blog
The SWOG/Hope Foundation Impact Award program
The SWOG/Hope Foundation Impact Award program is designed to support the early and conceptual stages…
Dec 20, 2024, 18:25 | Drugs
Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia
On 19th December, Nurix Therapeutics has announced that the U.S. Food and Drug Administration (FDA)…
Dec 20, 2024, 18:00 | Science
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America
Cancer and Aging Research Group shared a study by Myrna Candelaria et al. on X:…
Dec 20, 2024, 17:59 | Insight
BGICC 2025: The 17th Breast, Gynecological and Immuno-oncology International Cancer Conference Key People
The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) is a premier event…
All: 91 Posts: 11 - 20
Special Coverage